Social Reintegration of Hodgkin's Survivors Impeded by Fatigue

This article originally appeared here.
Share this content:
Social Reintegration of Hodgkin's Survivors Impeded by Fatigue
Social Reintegration of Hodgkin's Survivors Impeded by Fatigue

WEDNESDAY, Oct. 12, 2016 (HealthDay News) -- Severe fatigue (sFA) can impede social reintegration in Hodgkin's lymphoma (HL) survivors, according to a study published online Oct. 3 in the Journal of Clinical Oncology.

Karolin Behringer, M.D., from the University Hospital of Cologne in Germany, and colleagues examined data on health-related quality of life for 4,529 patients enrolled in the German Hodgkin Study Group's fifth generation of clinical trials in HL. sFA was assessed before and up to nine years after therapy.

The researchers found that 37 percent of patients reported sFA at baseline; during follow-up, sFA varied from 20 to 24 percent. There was a correlation for baseline sFA with significantly impaired progression-free survival, and a trend toward impaired overall survival, which could be overcome for patients receiving highly effective HL therapies. In survivors there was a significant negative association for sFA and employment: five years after therapy, 51 percent of female survivors and 63 percent of males with sFA were working or in professional education, compared with 78 and 90 percent of those without sFA (adjusted P < 0.001). There was a correlation for sFA with financial problems and the number of visits to a general practitioner and medical specialists.

"This observation underscores the need to address fatigue as a significant diagnosis when treating patients with and survivors of cancer," the authors write.

Several authors disclosed financial ties to the biopharmaceutical industry.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »